BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 16680939)

  • 1. Detection of a novel nonsense mutation in the interleukin 2 receptor gamma gene causing X-linked severe combined immunodeficiency.
    Cohen L; Hirschfeld AF; Junker AK; Davis J; Turvey SE
    Ann Allergy Asthma Immunol; 2006 Apr; 96(4):632. PubMed ID: 16680939
    [No Abstract]   [Full Text] [Related]  

  • 2. A novel splice-site mutation in the common gamma chain (gammac) gene IL2RG results in X-linked severe combined immunodeficiency with an atypical NK+ phenotype.
    Ginn SL; Smyth C; Wong M; Bennetts B; Rowe PB; Alexander IE
    Hum Mutat; 2004 May; 23(5):522-3. PubMed ID: 15108287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Female germ line mosaicism as the origin of a unique IL-2 receptor gamma-chain mutation causing X-linked severe combined immunodeficiency.
    Puck JM; Pepper AE; Bédard PM; Laframboise R
    J Clin Invest; 1995 Feb; 95(2):895-9. PubMed ID: 7860773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel mutation in the interleukin-2 receptor gamma gene as the cause of lymphopenia in a neonate vertically exposed to human immunodeficiency virus.
    Neubert J; Meindl A; Theisen A; Adams O; Schulz A; Feyen O; Niehues T
    Pediatr Infect Dis J; 2005 Feb; 24(2):187-9. PubMed ID: 15702055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LMO2 and gene therapy for severe combined immunodeficiency.
    Fischer A; Abina SH; Thrasher A; von Kalle C; Cavazzana-Calvo M
    N Engl J Med; 2004 Jun; 350(24):2526-7; author reply 2526-7. PubMed ID: 15190153
    [No Abstract]   [Full Text] [Related]  

  • 6. Detection of three nonsense mutations and one missense mutation in the interleukin-2 receptor gamma chain gene in SCIDX1 that differently affect the mRNA processing.
    Markiewicz S; Subtil A; Dautry-Varsat A; Fischer A; de Saint Basile G
    Genomics; 1994 May; 21(1):291-3. PubMed ID: 8088810
    [No Abstract]   [Full Text] [Related]  

  • 7. Activation of the T-cell oncogene LMO2 after gene therapy for X-linked severe combined immunodeficiency.
    McCormack MP; Rabbitts TH
    N Engl J Med; 2004 Feb; 350(9):913-22. PubMed ID: 14985489
    [No Abstract]   [Full Text] [Related]  

  • 8. Efficient detection of thirty-seven new IL2RG mutations in human X-linked severe combined immunodeficiency.
    Niemela JE; Puck JM; Fischer RE; Fleisher TA; Hsu AP
    Clin Immunol; 2000 Apr; 95(1 Pt 1):33-8. PubMed ID: 10794430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atypical X-linked severe combined immunodeficiency due to possible spontaneous reversion of the genetic defect in T cells.
    Stephan V; Wahn V; Le Deist F; Dirksen U; Broker B; Müller-Fleckenstein I; Horneff G; Schroten H; Fischer A; de Saint Basile G
    N Engl J Med; 1996 Nov; 335(21):1563-7. PubMed ID: 8900089
    [No Abstract]   [Full Text] [Related]  

  • 10. Arrested rearrangement of TCR V beta genes in thymocytes from children with X-linked severe combined immunodeficiency disease.
    Sleasman JW; Harville TO; White GB; George JF; Barrett DJ; Goodenow MM
    J Immunol; 1994 Jul; 153(1):442-8. PubMed ID: 8207253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutation analysis should be performed to rule out gammac deficiency in children with functional severe combined immune deficiency despite apparently normal immunologic tests.
    Somech R; Roifman CM
    J Pediatr; 2005 Oct; 147(4):555-7. PubMed ID: 16227049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IL-2R gamma gene microdeletion demonstrates that canine X-linked severe combined immunodeficiency is a homologue of the human disease.
    Henthorn PS; Somberg RL; Fimiani VM; Puck JM; Patterson DF; Felsburg PJ
    Genomics; 1994 Sep; 23(1):69-74. PubMed ID: 7829104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alport syndrome. Molecular genetic aspects.
    Hertz JM
    Dan Med Bull; 2009 Aug; 56(3):105-52. PubMed ID: 19728970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin-2 (IL-2) receptor gamma chain mutations in X-linked severe combined immunodeficiency disease result in the loss of high-affinity IL-2 receptor binding.
    DiSanto JP; Dautry-Varsat A; Certain S; Fischer A; de Saint Basile G
    Eur J Immunol; 1994 Feb; 24(2):475-9. PubMed ID: 8299698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carrier frequency of a nonsense mutation in the adenosine deaminase (ADA) gene implies a high incidence of ADA-deficient severe combined immunodeficiency (SCID) in Somalia and a single, common haplotype indicates common ancestry.
    Sanchez JJ; Monaghan G; Børsting C; Norbury G; Morling N; Gaspar HB
    Ann Hum Genet; 2007 May; 71(Pt 3):336-47. PubMed ID: 17181544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incontinentia pigmenti in a newborn with a novel nonsense mutation in the NEMO gene.
    Has C; Danescu S; Volz A; Nöh F; Technau K; Bruckner-Tuderman L
    Br J Dermatol; 2007 Feb; 156(2):392-3. PubMed ID: 17223894
    [No Abstract]   [Full Text] [Related]  

  • 17. Interleukin 7 receptor alpha-chain-mutation severe combined immunodeficiency without lymphopenia: correction with haploidentical T-cell-depleted bone marrow transplantation.
    Ponda P; Schuval SJ; Kaplan B; Logalbo P; Roberts JL; Bonagura VR
    Ann Allergy Asthma Immunol; 2006 Dec; 97(6):755-8. PubMed ID: 17201233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure of the quaternary complex of interleukin-2 with its alpha, beta, and gammac receptors.
    Wang X; Rickert M; Garcia KC
    Science; 2005 Nov; 310(5751):1159-63. PubMed ID: 16293754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of five retrovirus vectors containing the human IL-2 receptor gamma chain gene for their ability to restore T and B lymphocytes in the X-linked severe combined immunodeficiency mouse model.
    Avilés Mendoza GJ; Seidel NE; Otsu M; Anderson SM; Simon-Stoos K; Herrera A; Hoogstraten-Miller S; Malech HL; Candotti F; Puck JM; Bodine DM
    Mol Ther; 2001 Apr; 3(4):565-73. PubMed ID: 11319919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective growth advantage of wild-type lymphocytes in X-linked SCID recipients.
    Kume A; Koremoto M; Mizukami H; Okada T; Hanazono Y; Sugamura K; Ozawa K
    Bone Marrow Transplant; 2002 Jul; 30(2):113-8. PubMed ID: 12132050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.